How AstraZeneca’s vaccine was hit by flawed trials, defects and politics — but might still save the world
As AstraZeneca’s top managers held a virtual meeting on January 25, they were interrupted by breaking news. Germany’s Handelsblatt newspaper reported that the company’s Covid-19 vaccine — seen as one Continue Reading
